Literature DB >> 11518190

Monocyte chemoattractant protein-1 enhances and interleukin-10 suppresses the production of inflammatory cytokines in adult rat cardiomyocytes.

J K Damås1, P Aukrust, T Ueland, A Odegaard, H G Eiken, L Gullestad, O M Sejersted, G Christensen.   

Abstract

OBJECTIVE: Chemokines control the migration of leukocytes to inflamed tissue, and in particular monocyte chemoattractant protein (MCP)-1 has been implicated in the pathogenesis of several cardiovascular disorders such as chronic heart failure (CHF) and myocarditis. We hypothesised that MCP-1 may directly contribute to an inflammatory response in the cardiomyocytes, and in the present study we examined in adult rat cardiomyocytes: (i) the effect of tumour necrosis factor (TNF)alpha on MCP-1 production, (ii) the effect of MCP-1 on production of other inflammatory cytokines, and (iii) if the anti-inflammatory cytokine interleukin (IL)-10 could suppress any TNFalpha-induced MCP- 1 production.
METHODS: We used enzyme immunoassays, RNase protection assays and slot blot analysis to measure protein and mRNA levels of various cytokines in adult rat cardiomyocyte cultures.
RESULTS: (i) We found a approximately 6.4-fold increase of the MCP-1 level accompanied by an increase in MCP-1 mRNA accumulation in cardiomyocyte cultures after TNFalpha stimulation. (ii) In contrast, TNFalpha had no effect on IL-10 and only a modest effect on IL-1beta and IL-6 levels in these cells. (iii) Importantly, MCP-1 stimulated inflammatory response in cardiomyocytes by enhancing IL- 1beta and IL-6 levels in these cells as found at both the protein and mRNA level. (iv) Co-stim-ulation with IL-10 resulted in a approximately 55% reduction in TNFalpha-stimulated MCP-1 levels in cardiomyocyte culture supernatants.
CONCLUSION: The present study demonstrates for the first time that MCP- 1 can directly affect cardiomyocytes, and we introduce MCP-1 as a potential enhancer and IL- 10 as a potential suppresser of inflammatory responses within the myocardium.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11518190     DOI: 10.1007/s003950170042

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  8 in total

Review 1.  Chemokines in myocardial failure -- pathogenic importance and potential therapeutic targets.

Authors:  P Aukrust; J K Damås; L Gullestad; S S Frøland
Journal:  Clin Exp Immunol       Date:  2001-06       Impact factor: 4.330

2.  One day from dyspnea to death--unsuccessful application of extracorporeal membrane oxygenation in toxoplasma myocarditis following bone marrow transplantation.

Authors:  J Hadem; F Schröder; T Winkler; B Gohrbandt; D Fischer; T Korte; H Drexler
Journal:  Clin Res Cardiol       Date:  2006-06-20       Impact factor: 5.460

3.  Pharmacological activation of the prostaglandin E2 receptor EP4 improves cardiac function after myocardial ischaemia/reperfusion injury.

Authors:  Keiichi Hishikari; Jun-ichi Suzuki; Masahito Ogawa; Kazuya Isobe; Teisuke Takahashi; Michihito Onishi; Kiyoshi Takayama; Mitsuaki Isobe
Journal:  Cardiovasc Res       Date:  2008-09-18       Impact factor: 10.787

4.  Inhibition of monocyte chemoattractant protein-1 prevents diaphragmatic inflammation and maintains contractile function during endotoxemia.

Authors:  Katherine Labbe; Gawiyou Danialou; Dusanka Gvozdic; Alexandre Demoule; Maziar Divangahi; John H Boyd; Basil J Petrof
Journal:  Crit Care       Date:  2010-10-07       Impact factor: 9.097

5.  MCP-1 promotes detrimental cardiac physiology, pulmonary edema, and death in the cpk model of polycystic kidney disease.

Authors:  Sally M Salah; James D Meisenheimer; Reena Rao; Jacqueline D Peda; Darren P Wallace; Dawson Foster; Xiaogang Li; Xiaoyan Li; Xia Zhou; Julian A Vallejo; Michael J Wacker; Timothy A Fields; Katherine I Swenson-Fields
Journal:  Am J Physiol Renal Physiol       Date:  2019-05-15

6.  Association study of MCP-1 promoter polymorphisms with the susceptibility and progression of sepsis.

Authors:  Junbing He; Yuhua Chen; Yao Lin; Wenying Zhang; Yujie Cai; Feng Chen; Qinghui Liao; Zihan Yin; Yan Wang; Shoubao Tao; Xiaoli Lin; Pengru Huang; Lili Cui; Yiming Shao
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

7.  Beneficial effects of andrographolide in a rat model of autoimmune myocarditis and its effects on PI3K/Akt pathway.

Authors:  Qi Zhang; Li-Qun Hu; Hong-Qi Li; Jun Wu; Na-Na Bian; Guang Yan
Journal:  Korean J Physiol Pharmacol       Date:  2019-02-15       Impact factor: 2.016

8.  Successful use of mRNA-nucleofection for overexpression of interleukin-10 in murine monocytes/macrophages for anti-inflammatory therapy in a murine model of autoimmune myocarditis.

Authors:  Oliver Zimmermann; Jörg M Homann; Anna Bangert; Anna-Maria Müller; Georgi Hristov; Stefan Goeser; Juliane M Wiehe; Stefan Zittrich; Wolfgang Rottbauer; Jan Torzewski; Gabriele Pfitzer; Hugo A Katus; Ziya Kaya
Journal:  J Am Heart Assoc       Date:  2012-12-19       Impact factor: 5.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.